Efficacy of once- and twice-daily administration of budesonide via Turbuhaler® as initial therapy in patients with mild persistent asthma

Respiratory Medicine

Volumn 93, Issue 4, 1999, Pages 230-235

  Herjavecz, I ^a,d   Blomqvist, P ^b   Serrano, A ^c  

^a Orszagos Koranyi Tbc es Pulmonologiai Intezet   (Hungary)

^b ASTRAZENECA R AND D   (Sweden)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^d NATIONAL KORANYI INSTITUTE OF PULMONOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BUDESONIDE;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY;

EID: 0032896559     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90018-5     Document Type: Article

References (13)

1. Laitinen LA, Laitinen A, Haahtela T. Airway mucosal inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis 1993; 147: 697-704.
2. Juniper EF, Kline PA, Vanzieleghem MA, Ramsdale EH, O'Byrne PM, Hargreave FE. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142: 832-836.
3. O'Byrne PM, Cuddy L, Taylor DW, Birch S, Morris J, Syrotuik J. Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care practice. Can Respir J 1996; 3: 169-175.
4. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Reinikainen K, Selroos O, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA. Comparison of a beta2-agonist, terbutaline, with an inhaled corticosteroid, BUD, in newly diagnosed asthma. N Engl J Med 1991; 325: 388-392.
5. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA. Effect of reducing or discontinuing inhaled BUD in patients with mild asthma. N Engl J Med 1994; 331: 700-705.
6. Agertoft L, Pedersen S. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children. Respir Med 1994; 88: 373-381.
7. Toogood JH, Baskerville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982; 70: 288-298.
8. Jones AH, Langdon CG, Lee PS, Lingham SA, Nankant JP, Follows RMA, Tollemar U, Richardson PD. Pulmicort® Turbohaler® once daily as initial prophylactic therapy for asthma. Respir Med 1994; 88: 293-299.
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Statement of the American Thoracic Society. Am Rev Respir Dis 1987; 136:: 225-244.
10. Quanjer PH, Tammeling GJ, Cotes JE, Pedersen OF, Peslin R, Yernault JC. Standardization of lung function tests. European Community for Steel and Coal. Eur Respir J 1993; 6 (Suppl. 16): 5-40.
11. Campbell LM, Watson DG, Venables TL, Taylor MD, Richardson PD. Once daily budesonide Turbohaler compared with placebo as initial prophylactic therapy for asthma. Br J Clin Res 1991; 2: 111-122.
12. Chisholm S, Knuistingh Neven A, Petri H. Once daily budesonide 200 mcg is as effective as twice daily 100 mcg in the treatment of mild asthma. Am J Respir Crit Care Med 1996; 153: A343.
13. Venables TL, Addlestone MB, Smithers AJ, Blagden MD, Weston D, Gooding T, Carr EP, Follows RMA. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbohaler and twice daily fluticasone propionate via disc-inhaler at an equal daily dose of 400 μg in adult asthmatics. Br J Clin Res 1996; 7: 15-32.